Navigation Links
Market Publishers Ltd and GenericsWeb Sign Partnership Agreement
Date:12/27/2010

LONDON, Dec. 27, 2010 /PRNewswire/ -- Market Publishers Ltd and GenericsWeb Pty Ltd signed partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorized to distribute and sell GenericsWeb research reports.

Mrs. Alla Martin, Head of Partner Relations Department, mentioned in her comments on the agreement: "GenericsWeb is a highly professional company whose title speaks for itself – the company focuses on the pipeline products, new drugs developments, and extended patent information. We are sure that our clients will develop much interest in the products offered by GenericsWeb, among which there are regularly updated news and articles, business intelligence, industry links, product development services and e-newsletters."

In-demand market reports by GenericsWeb:

  • Repaglinide - Comprehensive Patent Search
  • Ribavirin - Comprehensive Patent Search
  • Riluzole - Comprehensive Patent Search
  • Rimonabant - Comprehensive Patent Search
  • Risedronic Acid - Comprehensive Patent Search
  • Risperidone - Comprehensive Patent Search
  • Ritonavir - Comprehensive Patent Search
  • Rituximab - Comprehensive Patent Search
  • Rivaroxaban - Comprehensive Patent Search
  • Rivastigmine - Comprehensive Patent Search

  • Each of the above mentioned reports is a regularly updated, professional patent search which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

    Each Patent Search features:

  • Comprehensive patent searching, covering the world's key territories;
  • Identifies patents covering molecule, formulation, process, use, combination and assay techniques;
  • Patent identification, categorisation and interpretation;
  • Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims;
  • Manual filtration of patents not relevant to generic development;
  • Updated on a monthly basis, including changes to patent families, statuses, and litigation;
  • Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers.

  • More details on GenericsWeb and their reports can be found at http://marketpublishers.com/members/genericsweb/info.htmlCONTACTS The Market Publishers, Ltd.Mrs. Alla MartinTel: +44 208 144 6009Fax: +44 207 900 3970ps@marketpublishers.comwww.marketpublishers.com
    '/>"/>

    SOURCE The Market Publishers Ltd
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
    2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
    3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
    4. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
    5. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
    6. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
    7. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
    8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
    9. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
    10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
    11. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/18/2017)... In China , we say Health is ... China,s Healthy Strategy originates. 2016 is ... and Social Development of the People,s Republic of ... council of the People,s Republic of China ... plan, identifying medical devices as one of the main breakthrough ...
    (Date:1/18/2017)... 2017 Ximbio, a non-profit online one-stop-shop ... has opened its first North American headquarters in Kendall Square, ... ... Ximbio following its launch in October 2014 as a business ... commercialization arm of the foundation Cancer Research UK. ...
    (Date:1/18/2017)... Drug Administration CSL CureVac Daiichi Sankyo ... Administration FORT Fresenius Pharmaceuticals Gamma Vaccines ... GlaxoWellcome Global Influenza Programme Grippol ... Systems Indian Association of Paediatrics Janssen Pharmaceuticals ... Krka Pharmaceuticals Medicago Medicare MedImmune ...
    Breaking Medicine Technology:
    (Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... manage it from the number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive ... go untreated. , Certain Dri created this infographic to explain the seven types ...
    (Date:1/18/2017)... ... January 18, 2017 , ... The V Foundation for Cancer Research, a ... endurance training and fundraising team, to compete in the Boston Marathon on April 17. ... finish the world’s oldest annual marathon to join Team V and support the Foundation’s ...
    (Date:1/18/2017)... ... January 18, 2017 , ... Park ... financial planning services to families and business owners in the greater Kansas City ... children with developmental disabilities. , The Lakemary Center is a comprehensive educational resource ...
    (Date:1/18/2017)... NJ (PRWEB) , ... January 18, 2017 , ... ... care communications company, launched a new website for its Center for Biosimilars, announced ... will include the latest developments in the field of biosimilars through thought leader ...
    (Date:1/18/2017)... ... January 18, 2017 , ... Floundering on New Year’s resolutions? Need an ... time for a reset. The U.S. Apple Association agrees and recommends starting each ... factors that contribute to heart disease. , The U.S. Apple Association – which represents ...
    Breaking Medicine News(10 mins):